Sign Up Today and Learn More About MEDFAR Clinical Solutions Stock
Invest in or calculate the value of your shares in MEDFAR Clinical Solutions or other pre-IPO companies through EquityZen's platform.
MEDFAR Clinical Solutions Stock (MRCS)
MEDFAR Clinical Solutions provides MYLE, an electronic medical records web application for medical teams.
About MEDFAR Clinical Solutions Stock
Founded
2010
Industries
Messaging and Telecommunications, Content and Publishing, Sports
MEDFAR Clinical Solutions Press Mentions
Stay in the know about the latest news on MEDFAR Clinical Solutions
All eyes on the fastest growing tech companies
theglobeandmail • Nov 07, 2024
MEDFAR, Fastest-growing EMR/EHR Provider, Announces Successful Entry Into the U.S. Primary Care Market with COMTRON Integration
prnewswire • Aug 08, 2024
Deloitte Canada announces its annual Technology Fast 50 program winners
www2 • Mar 02, 2024
Canada's private tech firms gather to talk AI, growth
betakit • Dec 20, 2023
Welcome to BetaKit’s startup stories of the week! Here, you will find the week’s most important news, features, and editorials published on BetaKit. If…
betakit • Jul 17, 2021
MEDFAR Clinical Solutions Management
Leadership team at MEDFAR Clinical Solutions
Co-Founder, President & CEO
Elias Farah
EVP of Business Development and Public Relations
Benoit Arbour
Join now and verify your accreditation status to gain access to:
- MEDFAR Clinical Solutions Current Valuation
- MEDFAR Clinical Solutions Stock Price
- MEDFAR Clinical Solutions Management
- Available deals in MEDFAR Clinical Solutions and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- MEDFAR Clinical Solutions Cap Table and Funding History by Share Class and Liquidity Preferences
- MEDFAR Clinical Solutions Revenue and Financials
- MEDFAR Clinical Solutions Highlights
- MEDFAR Clinical Solutions Business Model
- MEDFAR Clinical Solutions Risk Factors
- MEDFAR Clinical Solutions Research Report from SACRA Research
Trading MEDFAR Clinical Solutions Stock
How to invest in MEDFAR Clinical Solutions stock?
Accredited investors can buy pre-IPO stock in companies like MEDFAR Clinical Solutions through EquityZen funds. These investments are made available by existing MEDFAR Clinical Solutions shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell MEDFAR Clinical Solutions stock?
Shareholders can sell their MEDFAR Clinical Solutions stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
